Title: Cardiology Grand Rounds: Lessons Learned from DOAC's and the New Factor XI Anti-thrombotic Therapies Being Studied
Speaker: Manesh R. Patel, MD
Chief, Division of Cardiology
Co-Director, Duke Heart Center
Duke Clinical Research Institute
Duke University, Durham, NC
Disclosures:
Research Grants: PACIFIC-AF: Bayer, Janssen, Heartflow, Idorsia, NHLBI, Novartis
Advisory Board/Consulting: Bayer, Janssen, Heartflow, Medscape
Objectives:
•Understand the Net-Benefit of Warfarin and then NOACs in AFib
•Understand the use of NOACs and limitations
•Understand the Factor XI therapy and promise in A. Fib